ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
Bulls and Bears Of The Week: Disney, Amazon, Uber, Apple And Why Netflix Is Facing A Defamation Suit
Benzinga has examined the prospects for many investors' favorite stocks over the past week, here's a look at some of our top stories.
